The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Vaccines, Blood & Biologics
From: Peng, Ze
Sent: Tuesday, February 07, 2012 3:24 PM
To: Rana, Pratibha; Kirschbaum, Nancy
Cc: Lee, Timothy
Subject: RE: Filing Meeting/STN 125416/0/OctaplastLG from Octapharma
Good afternoon, Pratibha and Nancy:
Regarding the original BLA under STN 125416 submitted by Octapharma for Solvent/Detergent treatment human plasma, OctaplasLG, I did a preliminary review on two sections, Stability (3.2.S.7 and 3.2.P.8) and Adventitious Agents Safety Evaluation (3.2.A.2). I found that the information provided in these sections will allow me to perform a meaningful review. Therefore, this submission can be filed.